Register entry

Mayne Pharma Commercial LLC.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
11
Labeller names
2
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

11

11 active NDC listings: 11 human prescription drug. By marketing category: ANDA 5, NDA 4, NDA AUTHORIZED GENERIC 2.

Dosage formNDCs
cream2
gel2
tablet2
tablet, delayed release2
capsule, gelatin coated1
solution1
tablet, film coated1
RouteNDCs
oral6
topical5
Labeller name on the listingNDCs
mayne pharma commercial llc10
mayne pharma commercial llc.1
Catalogue

Marketed products

11
BrandGeneric nameForm / routeNDC
ADAPALENEADAPALENEgel, topical68308-666NDA AUTHORIZED GENERIC
Chlorzoxazonechlorzoxazonetablet, oral51862-339ANDA
DORYX MPCdoxycycline hyclatetablet, delayed release, oral51862-560NDA
DapsoneDapsonegel, topical68308-342ANDA
Doxycycline HyclateDoxycycline Hyclatetablet, delayed release, oral68308-716NDA AUTHORIZED GENERIC
EpsolayBenzoyl Peroxidecream, topical51862-772NDA
Methamphetamine HydrochlorideMETHAMPHETAMINE HYDROCHLORIDEtablet, oral68308-115ANDA
Tamoxifen CitrateTamoxifen Citratetablet, film coated, oral51862-643ANDA
TolsuraItraconazolecapsule, gelatin coated, oral51862-462NDA
TwyneoBenzoyl Peroxide and Tretinoincream, topical51862-771NDA
tavaboroletavaborolesolution, topical51862-690ANDA
Compare

Other companies listing adapalene

Enquiry

Common questions

Is Mayne Pharma Commercial LLC. FDA approved?
Mayne Pharma Commercial LLC. holds no registered establishment of its own; 11 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Mayne Pharma Commercial LLC. make?
11 products are listed under Mayne Pharma Commercial LLC. in the openFDA NDC Directory, most often as cream; gel; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.